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Abstract
Background: Middle cerebral artery occlusion (MCAo) in mice results in a brain infarct, the
volume of which depends on the length of occlusion. Following permanent occlusion,
neuropathological changes – including a robust glial inflammatory response – also occur
downstream of the infarct in the spinal cord.
Methods: We have performed short, transient MCAo in mice to induce penumbral damage
spanning the motor cortex. A 30 minute MCAo using a poly-L-lysine-coated intraluminal suture
introduced through a common carotid artery incision was performed in 17 female C57BL/6 mice.
Five sham-operated mice received common carotid artery ligation without insertion of the suture.
Neurobehavioural assessments were performed during occlusion, immediately following
reperfusion, and at 24 and 72 hours post-reperfusion. Routine histological and
immunohistochemical studies were performed at 24 and 72 hours.
Results: In 11 of the surviving 16 mice subjected to MCAo, we observed a focal, subcortical
necrotic lesion and a reproducible, diffuse cortical lesion with accompanying upper motor neuron
involvement. This was associated with contralateral ventral spinal cord microglial priming without
significant reactive astrocytosis or lower motor neuron degeneration.
Conclusion: The advantages to this method are that it yields a reproducible cortical lesion, the
extent of which is predictable using behavioural testing during the period of ischemia, with upper
motor neuron involvement and downstream priming, but not full activation, of microglia in the
lumbar spinal cord. In addition, survival is excellent following the 30 minutes of occlusion, rendering
this a novel and useful model for examining the effects of microglial priming in the spinal motor
neuron pool.
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Neuroinflammation is a pathological feature of several
neurodegenerative conditions including amyotrophic lat-
eral sclerosis (ALS), which involves the selective degener-
ation of motor neurons in the brain and spinal cord.
There is controversy over the role of neuroinflammation
in the disease process. Microglia become activated and
proliferate in areas of neurodegeneration with disease
progression in human patients and in animal models of
the disease [1,2]. Anti-inflammatory therapies have
shown efficacy in mouse models of ALS [3-6], and acti-
vated microglia can have cytotoxic effects on motor neu-
rons in culture [7-10]. Microglial activation is a response
to damage signals from neurons and astrocytes. This acti-
vation is seen morphologically as a transition from a rest-
ing, ramified state to an active, amoeboid state through a
"primed" intermediate state [11].
Once activated, microglia have cytotoxic and phagocytic
potential. However, the role of primed microglia in the
early response to damage signals remains unclear. Primed
microglia express major histocompatibility class (MHC) II
molecules and have antigen presenting capabilities. Prim-
ing results in intensification of local surveillance and pro-
duction of pro- or anti-inflammatory cytokines [12]. It is
possible that microglia perform different tasks depending
on whether they are "primed" or "activated". We predict
that the function of primed microglia is to protect the dam-
aged neuron from further injury and enable recovery,
while activated microglia serve to remove the damaged
neuron in order to preserve proper function of surround-
ing cells. In order to examine this, we have developed a
model in which the function of primed microglia can be
studied. Ultimately, we intend to use this model to exam-
ine the effects of microglial priming on healthy motor
neurons and on motor neurons predisposed to develop
ALS-like pathology.
The induction of cerebral ischemia in animals is a com-
monly used method to investigate the pathophysiology of
stroke. A relatively non-invasive procedure has been
developed in rats and involves the insertion of an intralu-
minal suture into the Circle of Willis to occlude the mid-
dle cerebral artery (MCA) [13]. The suture can be removed
after a period of occlusion resulting in reperfusion of the
Circle of Willis and the production of a marked region of
infarct. This method has been modified for use in mice
[14,15]. However, this latter model suffers from a high
rate of mortality and inconsistencies in stroke outcome,
including high variability of lesion size. Because variabil-
ity in animal size, strain, and cerebrovascular anatomy
can directly affect the consistency of stroke outcome in
mice, modifications that include coating the suture mate-
rial with poly-L-lysine to enhance adhesion of the suture
to the vascular endothelium [16] and increasing occlusion
time to maximize infarct volume [17,18] have been intro-
duced. When coupled with a neurobehavioural assess-
ment, an accurate prediction of lesion severity can be
made during MCAo [17], thus allowing for the exclusion
of animals that are unlikely to harbour the necessary inf-
arct from further study. MCAo of 60 minutes or less leads
to a substantial recovery of function within 24 hours [17].
While longer occlusion times result in persistence of
behavioural symptoms including altered reflexes and con-
tralateral weakness, they are also associated with increased
mortality [15,19].
Most of the studies examining the cellular effects of cere-
bral ischemia have focused on the primary lesion in the
brain. However, neuropathological changes occur far
removed from the focal lesion epicentre in studies carried
out in rats [20,21]. These changes include a glial inflam-
matory response in the contralateral lumbar spinal cord
24 hours following permanent MCAo in which ventral
horn motor neurons that appear to be undergoing degen-
eration are engulfed by phagocytic microglia [20]. This is
accompanied by an increase in expression of pro-inflam-
matory cytokines and markers of oxidative stress 24–72
hours following permanent MCAo [21,22]. The mecha-
nism by which this inflammatory response is induced is
unknown. However, it has been suggested that it may be
due to transsynaptic degeneration mediated by ischemic
degeneration of the descending supraspinal (upper motor
neuron) pathways and an associated deafferentation of
the ventral spinal motor neurons [20]. This in turn is pos-
tulated to give rise to a glutamatergic injury of the postsy-
naptic lower motor neuron through release of presynaptic
glutamate, the activation of postsynaptic N-methyl-D-
aspartate (NMDA) receptors, and an accompanying
increased calcium influx [23]. The MCAo model has there-
fore provided a unique opportunity to observe the effects
of upper motor neuron injury on lower motor neurons
and surrounding glia in the rat.
In these experiments, we have developed a model of
murine MCAo that is easily quantifiable, reproducible in
terms of upper motor neuron involvement regardless of
the overall size of the cerebral infarct, and which gives rise
to microglial priming in the contralateral lumbar ventral
horn 24 hours and 72 hours post-reperfusion in mice. We
have observed that a 30 minute occlusion time was asso-
ciated with 100% survival at the 24 hour post-reperfusion
time interval. We propose that this model, easily per-
formed in mice, will allow for the study of microglial
priming in the lumbar spinal cord in a reproducible man-
ner that will be instrumental in determining the exact
roles of early microglial priming and activation, an event
that can apparently produce two very opposing outcomes
following neuronal injury.Page 2 of 9
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Animals
Female C57BL/6 mice were originally purchased from
Charles River Laboratories (Montreal) and bred in house.
Studies were carried out on mice aged six weeks, weighing
17–22 g independently of the estrous cycle. Cyclic
changes in estrogen levels may explain the relatively large
variability in the number of apoptotic neurons detected in
the brain following MCAo. Mice were kept in group cages
and allowed free access to food and water throughout the
duration of the study. All procedures were in accordance
with the Canadian Council for Animal Care and the Uni-
versity Council on Animal Care guidelines for research,
and all protocols involving animals, behavioural testing,
surgeries and animal maintenance were approved in
accordance with the above guidelines.
Surgical preparation and middle cerebral artery occlusion
The tip of the 5-0 monofilament suture to be used in the
MCAo was first blunted by heating over a flame and then
the distal 11 mm coated with poly-L-lysine (Sigma) (0.1%
in deionized water) and dried in a 60°C oven for 1 hour.
A point 11 mm from the blunt end was marked with silver
impregnation marker to render it visible through the arte-
rial wall.
Mice were placed in an induction chamber supplied with
oxygen at a rate of 1 L/min and isofluorane at 4%. Inject-
able chemical anaesthesia was avoided in order to acceler-
ate post-surgical awakening for immediate behavioural
observation. All mice were maintained on 1 L/min oxygen
supplemented with 1.5% isofluorane throughout the
duration of surgery using a small mask. Using an operat-
ing microscope, the left common carotid artery (CCA) was
exposed through a midline neck incision and dissected
free from surrounding tissue from 1 cm proximal to its
bifurcation to the base of the skull. The external carotid
artery (ECA) was dissected and coagulated near the origin
of the lingual and maxillary artery branches. The internal
carotid artery (ICA) was isolated and separated from the
adjacent vagus nerve. A 5-0 vicryl suture was tied around
the CCA 1 cm proximal to the bifurcation. The 2 cm poly-
L-lysine-coated suture was then inserted via a small inci-
sion in the CCA distal to where it was tied, but proximal
to the bifurcation, and advanced 11 mm from the CCA
bifurcation to occlude the middle cerebral artery (MCA).
A 5-0 vicryl suture was placed around the ICA and intralu-
minal nylon suture to prevent bleeding and movement of
the nylon suture. The neck skin was closed with 5-0 vicryl
sutures.
The mice were placed in separate cages and allowed to
awaken briefly from anaesthesia during the 30 minutes of
occlusion to permit neurobehavioural assessment. Fol-
lowing assessment, the mice were re-anaesthetized and
after 30 minutes of occlusion, the neck skin was re-
opened, the nylon occlusion suture carefully removed,
and the neck skin closed with 5-0 vicryl sutures.
In this method, and in contrast to the procedure reported
by Belayev and colleagues [17], the occipital artery
branches of the external carotid artery and the pterygopal-
entine artery were not coagulated or ligated. Kitagawa and
colleagues [15] showed that differences in cranial vascula-
ture, specifically the posterior communicating artery,
could affect the degree of ischemia and should be assessed
during occlusion by measuring cortical microperfusion.
Because we correlated neurobehavioural testing during
the occlusion with the ischemic lesion volume, this more
technically challenging evaluation could be avoided.
The mice were allowed to recover in separate cages and
given antibiotics (0.01 ml ampicillin, 50 mg/kg) and anal-
gesics (0.04 – 0.05 ml buprenorphine, 0.09 mg/kg) post-
surgery. Animals were also given up to 4 mL daily subcu-
taneous fluids throughout the recovery period and pro-
vided with a high peptide liquid nutritional supplement
(Peptamen) and rice pabulum on the cage floor for the
duration of post-operative study. The criterion for early
euthanasia was adhered to in the event of excessive weight
loss.
Sham-operated mice were prepared for surgery as above.
The left CCA was exposed through a midline neck inci-
sion, dissected free from surrounding tissue, and ligated
with a 5-0 vicryl suture 1 cm proximal to the bifurcation.
The neck skin was closed with 5-0 vicryl sutures.
Neurobehavioural assessment
Neurobehavioural evaluations consisted of two testing
batteries and were performed during occlusion (20 min-
utes after suture insertion), following recovery from reper-
fusion, 24 hours, and 72 hours post-reperfusion. The first
test battery consisted of 2 test items each scored on a scale
from 0–12 (0 = normal, 12 = severely impaired) [17]: the
postural reflex test to observe the animal's upper body
posture while being suspended by the tail [24]; and the
forelimb placing test to examine psychomotor responses
to tactile stimuli [25]. For the second battery, we
attempted to assess the motor function of each mouse
without handling. Each mouse was assigned a score of 0 –
4: 0 = no observable neurological deficit; 1 = failure to
extend the right forepaw; 2 = circling to the right; 3 = fall-
ing to the right; and 4 = cannot walk spontaneously [26].
Tissue preparation and lesion assessment
Based on the rat MCAo studies [21], we examined the spi-
nal cord 24 hours after reperfusion for the extent micro-
glial proliferation or activation and effects on lower motor
neurons. Mice were anaesthetized 24 hours (n = 8) or 72Page 3 of 9
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lowing sham operation (n = 5) via intraperitoneal injec-
tion of ketamine-xylazine mixture (0.03 ml/10 g) and
perfused transcardially with heparinized saline until the
outflow ran clear. Fixation was achieved with 25 ml/min
intracardial injection of 50 ml/100 g body weight of fixa-
tive (4% paraformaldehyde in PBS). Brains and spinal
cords were dissected out and placed in the same fixative
overnight at 4°C. The frontal brain and lumbar spinal
cord from L3-S1 was processed for paraffin-sectioning.
Five μm thick serial sections were cut in the coronal plane
and mounted on glass slides. Every 5th section was stained
with haematoxylin and eosin (H&E), or immunoreacted
using antibodies to detect macrophages (ionized calcium-
binding adaptor molecule-1 (IBA-1), Wako), astrocytes
(glial fibrillary acid protein (GFAP), BD Pharmingen) or
apoptosis (active caspase 3, BD Pharmingen).
Sections were dried overnight, deparaffinized, and rehy-
drated. Antigen retrieval was performed using boiling
high-pH TRIS-EDTA buffer following which the sections
were blocked for endogenous hydrogen peroxide (3%
hydrogen peroxide, 5 min.). Non-specific antibody bind-
ing was blocked (10% normal goat serum, 5% bovine
serum albumin (BSA) in PBS containing 0.3% Triton X-
100; 30 min.) and the sections then incubated with the
primary antibody (1 hr, room temperature). Primary anti-
bodies consisted of either polyclonal rabbit-anti-IBA-1
(1:1000), monoclonal mouse-anti-GFAP (1:75) or poly-
clonal rabbit-anti-active caspase 3 (1:500). All primary
antibodies were prepared in 5% BSA, 5% normal goat
serum, and 0.3% Triton X-100. Following this, sections
were incubated in secondary antibody (1:200 goat-anti-
rabbit or horse-anti-mouse in 5% normal goat serum, 5%
BSA, 0.3% Triton X-100 in PBS) for 30 minutes at room
temperature. The antigen:antibody complex was localized
using the avidin-biotin complex (ABC staining kit, Vector
Laboratories) as per the manufacturer's instructions. Sec-
tions were washed and developed for visualization in 0.3
mg/ml 3', 3-diaminobenzidine tetrahydrochloride (DAB,
Sigma) containing 0.01% hydrogen peroxide for 10 min-
utes and then washed thoroughly. Sections were counter-
stained with Harris's Haematoxylin and then mounted in
Cytoseal 60 (VWR). Negative control slides consisted of
the omission of the primary antibody.
All cell counts were carried out in defined areas main-
tained across all sections. For the quantification of the per-
cent IBA-1-positive area (to support the observation of an
increase in the number of primed microglia), images of
IBA-1-immunolabelled sections were captured using
Northern Eclipse imaging software. A threshold was
applied to the image which allowed for calculation of the
total area of immunoreaction and the percent immunore-
action in a defined area which was consistent across all
sections.
Statistical analysis
One-way ANOVAs were performed with Tukey post-hoc
tests for neuronal density, neuronal caspase 3 activation,
neurobehavioural assessment analysis, IBA-1 immunore-
activity assessment, and primed microglial cell counts,.
Results
Induction of cerebral ischemia with upper motor neuron 
involvement
Thirty minutes of MCAo resulted in diffuse penumbral
damage spanning both the subcortex and the cortex in 5
of 8 mice at the 24-hour time point and 6 of 8 mice at the
72 hour time point. In these mice a necrotic focal lesion
was clearly visible (Table 1, Figure 1a). Two of 5 mice that
did not exhibit cortical pathology did demonstrate behav-
ioural deficits during occlusion meeting the inclusion cri-
teria proposed by Belayev and colleagues [17]. All 5 mice
were excluded from further study.
In the remaining mice, all harbouring marked infarct
regions, microglial activation was prominent, extending
into the motor cortex of the lesioned hemisphere and not
the intact hemisphere (Figures 1b and 1c). The number of
large neurons in layer V of the primary motor cortex in
these mice was decreased in the lesioned hemisphere
compared to the intact hemisphere (Figures 1d–f, ANOVA
p < 0.01). This was accompanied by an apparent increase
in active caspase 3 immunoreactivity in the same region
that did not reach significance due to variability (Figures
1g–i, ANOVA p = 0.1133). We observed microglial activa-
tion (Figure 1j) and caspase 3 activation (Figure 1k) in the
corticospinal tract (CST) contralateral to MCAo, further
suggesting the presence of an injury upstream to ventral
horn motor neurons. Mice who did not display evidence
of any focal infarct region did not have any pathology
(glial or neuronal) in the motor cortex in either hemi-
sphere (Table 1).
Neurobehavioural deficits and mortality
During occlusion, all mice exhibited head rotation, eyelid
drooping and abnormal tongue holding consistent with
the development of a cerebral infarct. Interestingly, mice
were highly vocal throughout the course of the study. Ani-
mals were examined carefully for evidence of pain and
were not in apparent distress. Analgesics were adminis-
tered according to guidelines. Following reperfusion,
behavioural deficits were sustained with 12 of 16 mice
achieving scores above the inclusion cutoffs proposed by
Belayev and colleagues [17] suggesting the presence of a
lesion (Figure 2b). Eleven of these 12 mice had a marked
region of infarct and cortical pathology. Twenty-four
hours post-reperfusion most animals remained vocal withPage 4 of 9
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ure 2a–b). All animals survived 24 hours post-reperfusion
and maintained good body weight. Eight of 9 animals sur-
vived 72 hours post reperfusion.
Microglial priming in the contralateral lumbar ventral horn
There were significantly more microglia with primed mor-
phology in the ventral horn contralateral to MCAo than in
the ventral horn ipsilateral to MCAo 24 hours and 72
hours post-reperfusion (Figure 3a–c, e–f, ANOVA p <
0.05). The total area of IBA-1 immunoreaction was also
greater in the ventral horn contralateral to MCAo at both
time points (Figure 3d, ANOVA p < 0.01). Cell bodies
appeared thicker and processes were shorter (Figure 3c
and 3f). Often primed and ramified microglial processes
were enveloping large motor neurons (arrows in Figure 3f,
higher magnification in 3g).
Despite the observed change in microglial activation state
from ramified to primed, there was no difference observed
in the morphology of GFAP-immunolabelled astrocytes
in the ventral horns contralateral to MCAo compared with
ventral horns ipsilateral to MCAo 24 hours and 72 hours
post-reperfusion (Figure 3h–i). There was no significant
difference observed in the number of apoptotic motor
neurons in the ventral horns contralateral to MCAo com-
pared with ventral horns ipsilateral to MCAo 24 hours
and 72 hours post-reperfusion (Figure 3j–l).
Discussion
We have observed microglial priming in the lumbar spi-
nal cord following a contralateral MCAo of 30 minutes
duration in mice. The motor cortex was included in the
span of the diffuse lesion created by temporary MCAo.
Loss of larger neurons in layer V of the motor cortex was
confirmed and neuronal apoptosis in the same region was
observed. Despite this inflammatory response, we did not
observe morphological evidence of reactive astrocytosis or
caspase 3 activation in spinal motor neurons 24 hours
and 72 hours post-reperfusion. Based on morphological
criteria, microglia were primed and not fully activated.
However, the functional differences between primed
microglia in this model and microglia in models of activa-
tion remain to be determined.
Nerve lesion models have been useful in the study of the
effects of inflammation, executed primarily by microglia,
on injured neurons. Microglial activation can induce neu-
ronal repair through the release of anti-inflammatory
cytokines, neurotrophins and growth factors, and through
controlled phagocytosis of neurons damaged beyond
repair. Conversely, the response can be to enhance neuro-
nal injury through the release of pro-inflammatory
cytokines, reactive oxygen and nitrating species, and lyso-
somal proteases, and through chronic phagocytosis [12].
Here we report that a model of transsynaptic injury, in
which there is no direct injury to lower motor neurons,
results in a reproducible response of microglial priming in
the environment of intact motor neurons.
The mechanism by which an upper motor neuron lesion
gives rise to microglial priming in the contralateral lum-
bar cord is not known. However, neurotransmission
between upper and lower motor neurons of the corticos-
pinal tract is glutamatergic [27,28] and it is known that
ischemic neuronal injury results in the release of gluta-
mate from neurons residing in the primary lesion site.
This glutamatergic insult results in the subsequent activa-
Table 1: Summary of cases, indicating presence or absence of a focal infarct region and/or upper motor neuron (UMN) involvement, 
and neurobehavioural assessment (NBA) scores using the testing criteria of Belayev at al. [17] or Yang et al. [26].
Case Focal Infarct UMN Involvement Belayev et al. ([17]) 
NBA Score
Yang et al. ([26]) 
NBA Score
1-1 + + 12 3
1–2 + + 22 4
1–3 - - 1 1
1–4 + + 17 2.5
1–5 - - 22 4
1–6 - - 8 1
1–7 + + 22 2
1–8 + + 12 1
3-1 - - 0 0
3-2 + + 24 4
3-3 + + 18 3
3–4 - - 1 1
3–5 + + 16 3
3–6 + + 20 4
3–7 + + 14 2
3–8 + + 16 2Page 5 of 9
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(a) The focal necrotic infarct region resulting from 30-minute transient MCAo (magnification 20×)Figur 1
(a) The focal necrotic infarct region resulting from 30-minute transient MCAo (magnification 20×). In all cases in which a focal 
necrotic infarct region could be identified, it was subcortical with diffuse penumbral effects spanning cortically. (b) Evidence for 
penumbral damage spanning into the cortex as indicated by IBA-1 immunoreactivity (a marker for macrophages) in layer V of 
primary motor cortex in the lesioned hemisphere, (c) compared to the intact hemisphere. (d) Histogram depicting loss of large 
neurons in layer V of the motor cortex expressed as percent intact hemisphere (ANOVA p < 0.01) supported by representa-
tive images of H&E-stained sections from (e) the lesioned hemisphere and (f) the intact hemisphere. (g) Histogram depicting a 
trend towards caspase 3 activation in large neurons in layer V of the motor cortex expressed as fold change lesioned/intact 
(ANOVA, p > 0.05) supported by representative images of sections labelled with antibodies directed against active caspase 3 
(BD Pharmingen) from (h) the lesioned hemisphere and (i) the intact hemisphere. Dotted white lines indicate layer V. (j) Micro-
glial activation in the corticospinal tract contralateral to MCAo. (k) Active caspase 3-poitive neurons in the corticospinal tract 
contralateral to MCAo. Dotted lines in b-c, e-f, and h-i indicate layer V. Dotted lines in j-k indicate the spinal cord midline. All 
images taken at magnification 40× prior to reproduction unless noted.
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increased calcium influx [29]. Increased extracellular
glutamate is known to be associated with microglial acti-
vation and excitotoxic neuronal degeneration [30]. Treat-
ment with the NMDA receptor antagonist MK-801
resulted in a decreased glial inflammatory response in the
corticospinal tract of the spinal cord following MCAo in
rats [22]. This strongly suggests that microglial activation
is driven by signals from vulnerable lower motor neurons.
Several reports suggest that the physiological function of
activated microglia is to either support and enhance the
regeneration of neurons or, if neuronal damage is beyond
repair, to elicit a response that results in the death of the
neuron. These seemingly opposite outcomes beg the ques-
tion of what controls the process of activation, and suggest
that microglia may in fact be functionally different
depending on whether they are "primed" or "activated".
The function gained by the priming of microglia in the
lumbar spinal cord following MCAo is not clear. Here we
have shown that 24 hours and 72 hours post-reperfusion
microglia have adopted a primed phenotype and not an
amoeboid, phagocytic one. We speculate that in this state
their role is protective and involves a heightened surveil-
lance of glutamate levels and possibly the displacement of
damaged upper motor neuron axon terminals from
healthy lower motor neurons. A similar process has been
described as "synaptic stripping" and involves the
removal of presynaptic inputs from damaged post-synap-
tic neurons [31].
It would then be during this primed phase that the micro-
glia may be serving as a protective entity to the vulnerable
neuron. We have shown that during this time there is no
significant loss of lower motor neurons, a fact that sup-
ports our hypothesis that microglia are not fully activated
and phagocytic during this short period after occlusion.
We have shown that these mice do have lesions caused by
the occlusion that are predictable with behavioural testing
(using the criteria developed by Belayev et al. [17]), and
that the short time span of this occlusion does not con-
tribute to significant mortality.
While the overall role of the microglia during the period
directly following the occlusion was not the focus of this
study, we present a model system that will allow for the
examination of the roles of microglia when primed and
not fully activated. Additionally, this model will allow for
the process of transsynaptic injury, its relationship to
microglial activation, and the signalling events that are
involved during these processes to be studied in a repro-
ducible, and predictable model system both in induced
injury states and in murine disease models.
Conclusion
We have determined that 30 minutes of MCAo was suffi-
cient to induce a cortical lesion predictable with behav-
ioural testing, with upper motor neuron involvement and
a response of microglial priming in the contralateral lum-
bar spinal cord. Our findings strongly suggest that MCAo
results in upper motor neuron degeneration and subse-
quent transsynaptic effects on the lower motor neuron
environment resulting in perineuronal microglial prim-
ing, but not full microglial activation. This model will be
useful in the study of transsynaptic injury-induced or dis-
ease-induced microglial priming and the role of such
Neurobehavioural assessment (NBA) scores of mice using (a) the Belayev et al. [17] scale and (b) the Yang et al. scale [26], dur-ing occlusion (MCAo), following reperfusion (0), 24 hours post-rep rfusion and 72 hours post-reperfusion. All sham-operated mice exhibited score  of 0 at all tim  pointsFi re 2
Neurobehavioural assessment (NBA) scores of mice using (a) the Belayev et al. [17] scale and (b) the Yang et al. scale [26], dur-
ing occlusion (MCAo), following reperfusion (0), 24 hours post-reperfusion and 72 hours post-reperfusion. All sham-operated 
mice exhibited scores of 0 at all time points.Page 7 of 9
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(a) Quantification of the number of IBA-1-immunolabeled microglia with primed morphology in ventral horns ipsilateral to MCAo compared to ventral horns contralateral t  MCAo in mice 24 hours and 72 hours post-reperfusion and in sham-oper-ated mi eFigure 3
(a) Quantification of the number of IBA-1-immunolabeled microglia with primed morphology in ventral horns ipsilateral to 
MCAo compared to ventral horns contralateral to MCAo in mice 24 hours and 72 hours post-reperfusion and in sham-oper-
ated mice. (b) Representative image from a ventral horn ipsilateral and (c) contralateral to MCAo 24 hours post-reperfusion 
immunolabelled with antibodies directed against IBA-1 for visualization of microglia. (d) Quantification of the IBA-1 immunore-
activity expressed as percent ipsilateral IBA-1-immunoreacted area 24 hours and 72 hours post-reperfusion and in sham-oper-
ated mice. (e) Representative image from a ventral horn ipsilateral and (f) contralateral to MCAo 72 hours post-reperfusion 
immunolabelled with antibodies directed against IBA-1 for visualization of microglia. (g) Higher magnification image of microglia 
in close proximity to large motor neurons in ventral horns contralateral to MCAo (magnification 100×). (h) Representative 
image from a ventral horn ipsilateral and (i) contralateral to MCAo immunolabelled with antibodies directed against GFAP for 
visualization of astrocytes (magnification 100×, same section as in g). (j) Quantification of caspase 3 activation expressed as per-
cent ipsilateral number of caspase 3-positive motor neurons 24 hours and 72 hours post-reperfusion and in sham-operated 
mice. (k) Representative image from a ventral horn ipsilateral and (l) contralateral to MCAo 72 hours post-reperfusion immu-
nolabelled with antibodies directed against active caspase 3 for visualization of apoptotic cells. All images taken at magnification 
40× prior to reproduction unless noted.
Journal of Neuroinflammation 2008, 5:29 http://www.jneuroinflammation.com/content/5/1/29priming in the recovery from injury or during disease pro-
gression. The ability to predict lesion severity and the
excellent survival rate make it suitable for testing differ-
ences in the neuronal and microglial response to transsy-
naptic injury in animals with pre-existing disease,
including mouse models of neurodegenerative diseases
with associated inflammatory processes involving micro-
glial priming and activation such as ALS.
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